S&P 500   4,248.36 (+0.45%)
DOW   33,054.69 (+0.16%)
QQQ   358.98 (+1.14%)
AAPL   173.15 (+0.44%)
MSFT   318.46 (+1.62%)
META   304.89 (+1.31%)
GOOGL   135.14 (+2.05%)
AMZN   126.88 (+1.73%)
TSLA   257.87 (+4.60%)
NVDA   439.56 (+1.01%)
NIO   8.76 (+1.74%)
BABA   84.19 (-0.41%)
AMD   102.62 (+2.54%)
T   14.58 (-1.35%)
F   11.99 (-0.66%)
MU   68.00 (+0.25%)
CGC   0.75 (+10.10%)
GE   108.98 (+1.13%)
DIS   79.59 (+0.06%)
AMC   8.06 (+2.68%)
PFE   33.51 (-1.15%)
PYPL   58.21 (+1.59%)
NFLX   377.21 (+0.12%)
S&P 500   4,248.36 (+0.45%)
DOW   33,054.69 (+0.16%)
QQQ   358.98 (+1.14%)
AAPL   173.15 (+0.44%)
MSFT   318.46 (+1.62%)
META   304.89 (+1.31%)
GOOGL   135.14 (+2.05%)
AMZN   126.88 (+1.73%)
TSLA   257.87 (+4.60%)
NVDA   439.56 (+1.01%)
NIO   8.76 (+1.74%)
BABA   84.19 (-0.41%)
AMD   102.62 (+2.54%)
T   14.58 (-1.35%)
F   11.99 (-0.66%)
MU   68.00 (+0.25%)
CGC   0.75 (+10.10%)
GE   108.98 (+1.13%)
DIS   79.59 (+0.06%)
AMC   8.06 (+2.68%)
PFE   33.51 (-1.15%)
PYPL   58.21 (+1.59%)
NFLX   377.21 (+0.12%)
S&P 500   4,248.36 (+0.45%)
DOW   33,054.69 (+0.16%)
QQQ   358.98 (+1.14%)
AAPL   173.15 (+0.44%)
MSFT   318.46 (+1.62%)
META   304.89 (+1.31%)
GOOGL   135.14 (+2.05%)
AMZN   126.88 (+1.73%)
TSLA   257.87 (+4.60%)
NVDA   439.56 (+1.01%)
NIO   8.76 (+1.74%)
BABA   84.19 (-0.41%)
AMD   102.62 (+2.54%)
T   14.58 (-1.35%)
F   11.99 (-0.66%)
MU   68.00 (+0.25%)
CGC   0.75 (+10.10%)
GE   108.98 (+1.13%)
DIS   79.59 (+0.06%)
AMC   8.06 (+2.68%)
PFE   33.51 (-1.15%)
PYPL   58.21 (+1.59%)
NFLX   377.21 (+0.12%)
S&P 500   4,248.36 (+0.45%)
DOW   33,054.69 (+0.16%)
QQQ   358.98 (+1.14%)
AAPL   173.15 (+0.44%)
MSFT   318.46 (+1.62%)
META   304.89 (+1.31%)
GOOGL   135.14 (+2.05%)
AMZN   126.88 (+1.73%)
TSLA   257.87 (+4.60%)
NVDA   439.56 (+1.01%)
NIO   8.76 (+1.74%)
BABA   84.19 (-0.41%)
AMD   102.62 (+2.54%)
T   14.58 (-1.35%)
F   11.99 (-0.66%)
MU   68.00 (+0.25%)
CGC   0.75 (+10.10%)
GE   108.98 (+1.13%)
DIS   79.59 (+0.06%)
AMC   8.06 (+2.68%)
PFE   33.51 (-1.15%)
PYPL   58.21 (+1.59%)
NFLX   377.21 (+0.12%)

Dillard's (DDS) Stock Forecast, Price & News

$314.54
+0.03 (+0.01%)
(As of 12:47 PM ET)
Compare
Today's Range
$310.48
$317.42
50-Day Range
$308.89
$369.74
52-Week Range
$263.86
$417.86
Volume
42,155 shs
Average Volume
139,105 shs
Market Capitalization
$5.16 billion
P/E Ratio
6.60
Dividend Yield
0.32%
Price Target
$279.00

Dillard's MarketRank™ Forecast

Analyst Rating
Reduce
1.50 Rating Score
Upside/​Downside
11.3% Downside
$279.00 Price Target
Short Interest
Bearish
14.39% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-2.00
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$376,823 Sold Last Quarter
Proj. Earnings Growth
-8.47%
From $39.54 to $36.19 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.59 out of 5 stars

Retail/Wholesale Sector

183rd out of 210 stocks

Department Stores Industry

4th out of 4 stocks


DDS stock logo

About Dillard's (NYSE:DDS) Stock

Dillard's, Inc. operates retail department stores in the southeastern, southwestern, and midwestern areas of the United States. Its stores offer merchandise, including fashion apparel for women, men, and children; and accessories, cosmetics, home furnishings, and other consumer goods. The company also engages in the general contracting construction activities. Dillard's, Inc. was founded in 1938 and is based in Little Rock, Arkansas.

DDS Price History

DDS Stock News Headlines

What Is Dillard's, Inc.'s (NYSE:DDS) Share Price Doing?
Dillard's (DDS) Stock Rallies 11% in a Year: What's Ahead?
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Dillard’s Debuts Elizabeth Damrich for Antonio Melani
Best Momentum Stocks to Buy for August 28th
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Dillard's, Inc. Announces $0.25 Cash Dividend
Dillard's (DDS) Shares Skyrocket, What You Need To Know
Dillard's Q2 Results Down; Stock Dips In Premarket
Dillard's: Fiscal Q2 Earnings Snapshot
Dillard's (DDS) Q2 Earnings and Revenues Beat Estimates
Dillard`s Inc. - Ordinary Shares - Class A
Dr. Kristi A. Dillard
Dr. Christopher K. Daniel
Dillard's Inc.
Dillard's (DDS) Upgraded to Buy: Here's Why
See More Headlines
Receive DDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dillard's and its competitors with MarketBeat's FREE daily newsletter.

DDS Company Calendar

Ex-Dividend for 7/31 Dividend
6/29/2023
Dividend Payable
7/31/2023
Last Earnings
8/10/2023
Ex-Dividend for 10/30 Dividend
9/28/2023
Today
10/04/2023
Dividend Payable
10/30/2023
Next Earnings (Estimated)
11/09/2023
Fiscal Year End
1/31/2024

Industry, Sector and Symbol

Industry
Department stores
Sub-Industry
Department Stores
CUSIP
25406710
Employees
29,900
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$279.00
High Stock Price Forecast
$410.00
Low Stock Price Forecast
$150.00
Forecasted Upside/Downside
-11.3%
Consensus Rating
Reduce
Rating Score (0-4)
1.50
Research Coverage
2 Analysts

Profitability

Net Income
$891.64 million
Pretax Margin
14.80%

Debt

Sales & Book Value

Annual Sales
$6.87 billion
Cash Flow
$57.72 per share
Book Value
$93.71 per share

Miscellaneous

Free Float
11,087,000
Market Cap
$5.17 billion
Optionable
Optionable
Beta
0.98
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. William T. Dillard II (Age 78)
    Chairman & CEO
    Comp: $6.69M
  • Mr. Alex Dillard (Age 73)
    Pres & Director
    Comp: $6.69M
  • Mr. Chris B. Johnson (Age 52)
    Sr. VP & Co-Principal Financial Officer
    Comp: $1.72M
  • Mr. Phillip R. Watts (Age 61)
    Sr. VP, Co-Principal Financial Officer & Principal Accounting Officer
    Comp: $1.7M
  • Mr. Mike Dillard (Age 71)
    Exec. VP & Director
    Comp: $2.89M
  • Ms. Drue Matheny (Age 76)
    Exec. VP & Director
    Comp: $2.87M
  • Ms. Julie Johnson Guymon (Age 51)
    Director of Investor Relations
  • Mr. Dean L. Worley (Age 57)
    VP, Gen. Counsel & Corp. Sec.
  • Ms. Denise Mahaffy (Age 64)
    Sr. VP & Director
  • Mr. William T. Dillard III (Age 52)
    Sr. VP & Director













DDS Stock - Frequently Asked Questions

Should I buy or sell Dillard's stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dillard's in the last twelve months. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "reduce" DDS shares.
View DDS analyst ratings
or view top-rated stocks.

What is Dillard's' stock price forecast for 2023?

2 analysts have issued 1 year price targets for Dillard's' shares. Their DDS share price forecasts range from $150.00 to $410.00. On average, they expect the company's stock price to reach $279.00 in the next twelve months. This suggests that the stock has a possible downside of 11.3%.
View analysts price targets for DDS
or view top-rated stocks among Wall Street analysts.

How have DDS shares performed in 2023?

Dillard's' stock was trading at $323.20 on January 1st, 2023. Since then, DDS stock has decreased by 2.7% and is now trading at $314.59.
View the best growth stocks for 2023 here
.

Are investors shorting Dillard's?

Dillard's saw a decline in short interest in August. As of August 31st, there was short interest totaling 1,230,000 shares, a decline of 8.2% from the August 15th total of 1,340,000 shares. Based on an average daily trading volume, of 124,600 shares, the short-interest ratio is presently 9.9 days. Approximately 14.6% of the shares of the stock are sold short.
View Dillard's' Short Interest
.

When is Dillard's' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our DDS earnings forecast
.

How were Dillard's' earnings last quarter?

Dillard's, Inc. (NYSE:DDS) posted its quarterly earnings results on Thursday, August, 10th. The company reported $7.98 EPS for the quarter, beating analysts' consensus estimates of $4.66 by $3.32. The business earned $1.60 billion during the quarter, compared to analysts' expectations of $1.55 billion. Dillard's had a net margin of 11.88% and a trailing twelve-month return on equity of 46.53%. The company's quarterly revenue was down 1.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $9.30 earnings per share.

How often does Dillard's pay dividends? What is the dividend yield for Dillard's?

Dillard's declared a quarterly dividend on Thursday, August 17th. Stockholders of record on Friday, September 29th will be paid a dividend of $0.25 per share on Monday, October 30th. This represents a $1.00 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date is Thursday, September 28th. This is a positive change from the stock's previous quarterly dividend of $0.20.
Read our dividend analysis for DDS
.

Is Dillard's a good dividend stock?

Dillard's (NYSE:DDS) pays an annual dividend of $1.00 per share and currently has a dividend yield of 0.30%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 2.10%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, DDS will have a dividend payout ratio of 2.76% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for DDS.

What is Bill Dillard II's approval rating as Dillard's' CEO?

2,306 employees have rated Dillard's Chief Executive Officer Bill Dillard II on Glassdoor.com. Bill Dillard II has an approval rating of 46% among the company's employees. This puts Bill Dillard II in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Dillard's own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Dillard's investors own include Intel (INTC), Walt Disney (DIS), Micron Technology (MU), Cisco Systems (CSCO), CVS Health (CVS), General Electric (GE), Abbott Laboratories (ABT), Advanced Micro Devices (AMD), Gilead Sciences (GILD) and Hawkins (HWKN).

What is Dillard's' stock symbol?

Dillard's trades on the New York Stock Exchange (NYSE) under the ticker symbol "DDS."

Who are Dillard's' major shareholders?

Dillard's' stock is owned by many different institutional and retail investors. Top institutional investors include Park National Corp OH (0.01%). Insiders that own company stock include Chris B Johnson, Dean L Worley, J C Watts Jr, James I Freeman, James I Freeman, Mike Litchford, Reynie Rutledge, Tom W Bolin, Tony J Bolte and Warren A Stephens.
View institutional ownership trends
.

How do I buy shares of Dillard's?

Shares of DDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Dillard's' stock price today?

One share of DDS stock can currently be purchased for approximately $314.59.

How much money does Dillard's make?

Dillard's (NYSE:DDS) has a market capitalization of $5.17 billion and generates $6.87 billion in revenue each year. The company earns $891.64 million in net income (profit) each year or $47.68 on an earnings per share basis.

How many employees does Dillard's have?

The company employs 29,900 workers across the globe.

How can I contact Dillard's?

Dillard's' mailing address is 1600 CANTRELL ROAD, LITTLE ROCK AR, 72201. The official website for the company is www.dillards.com. The company can be reached via phone at (501) 376-5200, via email at julie.bull@dillards.com, or via fax at 501-376-5917.

This page (NYSE:DDS) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -